Skip to Content
U.S. Top 25 in Joint Replacement Ranked by Medicare
  • image description
  • image description
  • image description

Verano M. Hermida, MD

photo of Dr. Verano Hermida
(954) 958-0626
(954) 489-2842
Robotic Surgery
Sports Medicine
Holy Cross Medical Group: 

Office Hours
Monday, Tuesday, Wednesday 8 a.m.- 5 p.m.
Every other Thursday and Friday 8 a.m. - 5 p.m.

Click here to view Dr. Verano Hermida's Webisode.
Click here to view the Holy Cross Orthopedic Institute's ACL Repair Webisode

Focus Area
Orthopedic Surgery, Hip Replacement, Partial Knee Replacement, Robotic Total Hip Replacement, MAKOplasty® Total Hip Replacement, MAKOplasty® Partial Knee Replacement, Robotic Partial Knee Replacement, Sports Medicine, Arthroscopy, All Inside ACL Reconstruction (Arthroscopic Procedure), Sports Medicine

Specialized Training
Certified surgeon in robotic assisted total hip replacement surgery (MAKOplasty)

American Board of Orthopaedic Surgery

Residency / Fellowship 
Residency, Orthopedic Surgery (1982-1988)
  Temple University Hospital - Philadelphia, PA
  Shriner’s Hospital for Crippled Children, Philadelphia, PA
  St. Christopher’s Hospital for Children, Philadelphia, PA
  Abington Memorial Hospital

Internship, General Surgery - Episcopal Hospital - Philadelphia, PA (1986-1987)

Higher Education
Temple University School of Medicine - M.D. - Philadelphia, PA (1986)
Temple University - B.A. - Philadelphia, PA (1980)

Professional Associations 
Broward County Medical Society
Florida Medical Association
Broward County Orthopaedic Society
American Academy of Orthopaedic Surgeons

“A Randomized, Double-Blind Placebo-Controlled, Parallel Group Phase III Study of the Efficacy, Tolerability and Safety of Ketoprofen Topical Patch 20% (KTP) in the Treatment of Pain Associated with Grade 1 or Grade 2 Ankle Sprain or Strain” (2006-present)

“A Multi-Center, Double-Blind Placebo-Controlled Randomized Study of Bicifadine 200mg BID and Bicifadine 400mg BID and Bicifadine 400 TID in the Treatment of Chronic Low Back Pain” (2005-2006)

“A 13-Week Multi-Center, Double-Blind Double-Dummy, Placebo-Controlled Parallel Group Trial of Lumiracoxib (COX 189) 100mg OD in Patients with Primary Hip Osteoarthritis Using Celecoxib (200mg) as a Positive Control (2005-2006)

“Multi-Center, Randomized, Double-Blind Placebo-Controlled, Parallel Comparison of the Efficacy and Safety of Fixed Dose Extended-Release Hydrocodone Bitartrate/Acetaminophen in the Relief of Moderately Severe Chronic Osteoarthritis Pain in the Hip or Knee” (2004-Present)

“A Randomized Open Label Study Comparing the efficacy and Safety of Lidocaine 5% patch with Celecoxoib 200mg in Patients with Chronic Axial Low Back Pain” (2004-2006)

“A Phase 3, Randomized Multi-Center, Double-Blind Study Comparing the Analgesic Efficacy of the Extended Release Hydrocodone/Acetaminophen Tablets (Vicodin CR) to Placebo in Subjects with osteoarthritis” (2006-2007)

“A three-arm Study Comparing the Analgesic Efficacy and Safety of Tramadol HCI OAD Tablets at Doeses 100mg or 200mg and Placebo for the Treatment of Pain due to Osteoarthritis of the Knee” (2002-2003)

“A Sequential Two-Cohort (open label/double-blind, randomized parallel-group, placebo controlled), multi-dose trial to evaluate the efficacy and safety of 15 and 30 mg Extended-Release Hydrocodone (HCD) Given Every 12 Hours in Patients Following Arthroscopic Surgery” (2002)

“A Double-Blind, Comparative Study of Esterom (EST 321) 10% w/ solution and a Placebo Solution in Patients with Decreased Active Range of Motion of the Shoulder Associated with pain” (2002)


5597 N. Dixie Highway
Fort Lauderdale , FL 33334

HCMG Practice Locations


WebMD Arthritis Resources

More Rheumatoid Arthritis Resources

®2005-2011 WebMD, LLC. All rights reserved.

WebMD does not provide medical advice, diagnosis or treatment.

See additional information.


image description